Babies whose mothers consumed aspirin during pregnancy may be at more than double the risk of developing cerebral palsy, says a new finding.
Cerebral palsy is a neurological disorder that develops in early childhood and permanently damages the speech, movement and posture, vision and learning disabilities of a child.
The findings showed that babies born to mothers who took aspirin were almost two-and-a-half times more likely to develop the life-long and incurable condition.
While babies exposed to paracetamol were 30 per cent more likely to have overall cerebral palsy and 50 per cent more likely to have it on one side. Ibuprofen had little or no impact, the Daily Mail reported.
The biggest danger seemed to be from taking the painkillers in the middle stage of a pregnancy -- a crucial time for brain development.
This is because drugs such as paracetamol and aspirin could trigger toxic conditions in the developing brain that lead to permanent damage, or could disrupt the normal level of a mother's hormones needed to regulate brain development.
"The safety of these drugs now needs to be further evaluated and women should be further cautioned about their use in pregnancy," said researchers the from the University of Copenhagen in Denmark
For the study, published in the International Journal of Epidemiology, the researchers examined 1,85,617 mothers and their babies.
Around 5,000 of the women took aspirin and a similar number took ibuprofen. Nearly 90,000 -- almost half -- admitted taking paracetamol while expecting.
The team found 357 babies went on to develop brain-related problems - and those born to mothers who took aspirin were at the higher risk of developing cerebral palsy on both sides of the body.
--IANS
ng/rt/umer/pgh/
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
